Patent · US Active

Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients

US8252544B2 · kind B2 · utility

12Cited by

1References

16Claims

0Family size

Assignee

B.R.A.H.M.S GMBH · DE

Inventors

Andreas Bergmann · Berlin, DE
Nils Morgenthaler · Berlin, DE
Jana Papassotiriou · Berlin, DE
Joachim Struck · Berlin, DE
Stefan Anker · Berlin, DE

Key dates

Filing date	Mar 3, 2008
Grant date	Aug 28, 2012
Priority date	—
Expiry date	Apr 9, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/325
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to a method for the diagnosis, and/or risk stratification, and/or outcome prognosis of cardiac insufficiency for NYHA I patients, wherein a determination of the proANP marker, NT-proANP marker, or fragments or partial peptides thereof is carried out parallel to a determination of BNP, proBNP, and/or NT-proBNP on patients to be examined.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.